Cell Therapy News Volume 24.10 | Mar 27 2023

    0
    16







    2023-03-27 | CTN 24.10


    Cell Therapy News by STEMCELL Technologies
    Vol. 24.10 – 27 March, 2023
    TOP STORY

    Third Party CMV Viral Specific T-Cells for Refractory CMV Viremia and Disease after Hematopoietic Transplant

    In Phase I/II trials, scientists treated 67 subjects for CMV viremia or disease arising after allogeneic hematopoietic cell transplant with adoptive transfer of banked off-the-shelf, 3rd party, CMVpp65-sensitized T cells.
    [Journal Of Clinical Investigation]

    Abstract
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    PUBLICATIONSRanked by the impact factor of the journal

    Modular-Designed Engineered Bacteria for Precision Tumor Immunotherapy via Spatiotemporal Manipulation by Magnetic Field

    Investigators described an alternating magnetic field-manipulated tumor-homing bacteria developed by genetically modifying engineered Escherichia coli with Fe3O4@lipid nanocomposites.
    [Nature Communications]

    Full Article

    Rhodiola rosea Polysaccharides-Based Nanoparticles Loaded with DOX Boosts Chemo-Immunotherapy for Triple-Negative Breast Cancer by Re-educating Tumor-Associated Macrophages

    Scientists described a Rhodiola rosea polysaccharides-based hydrophobic delivery vector and achieved an additional helpful antitumor effect by modulating tumor-associated macrophages.
    [International Journal Of Biological Macromolecules]

    Abstract

    Potential of an Aligned Porous Hydrogel Scaffold Combined with Periodontal Ligament Stem Cells or Gingival Mesenchymal Stem Cells to Promote Tissue Regeneration in Rat Periodontal Defects

    A constructed aligned porous hydrogel scaffold carrying cells based on chitosan and oxidized chondroitin sulfate treated with a freeze-casting technique was fabricated, which aimed to induce the arrangement of periodontal tissue regeneration.
    [ACS Biomaterials Science & Engineering]

    AbstractGraphical Abstract

    Differentiation of Patient-Specific Void Urine-Derived Human Induced Pluripotent Stem Cells to Fibroblasts and Skeletal Muscle Myocytes

    Researchers established a workflow using induced pluripotent stem cell-derived fibroblasts and skeletal myocytes for urethral tissue regeneration, allowing scalable derivation, culture, and in vivo tracing of patient-specific fibroblasts and myocytes.
    [Scientific Reports]

    Full Article

    GD2 CAR-T Cells in Combination with Nivolumab Exhibit Enhanced Antitumor Efficacy

    A combined therapeutic strategy was tested by using GD2 CAR T together with Nivolumab, an anti-PD-1 monoclonal antibody. Animal studies suggested that GD2 CAR T effectively infiltrated into tumor tissue and significantly hampered tumor progression.
    [Translational Oncology]

    Full Article

    Novel Nanotherapeutics for Cancer Immunotherapy by CTLA-4 Aptamer-Functionalized Albumin Nanoparticle Loaded with Antihistamine

    To improve immune checkpoint blockade, fexofenadine, an antihistamine, was encapsulated into aptamer-modified nanostructure to make a drug-loaded nanoparticle.
    [Journal Of Cancer Research And Clinical Oncology]

    Abstract

    iPSC-Derived Tenocytes Seeded on Microgrooved 3D Printed Scaffolds for Achilles Tendon Regeneration

    Scientists assessed the application of novel 3D printed scaffolds and induced pluripotent stem cell-derived mesenchymal stem cells overexpressing the transcription factor Scleraxis as a new strategy for tendon defect repair.
    [Journal Of Orthopaedic Research]

    Abstract

    A Tunable Calcium Phosphate Coating to Drive In Vivo Osseointegration of Composite Engineered Tissues

    Investigators successfully fabricated polycaprolactone salt-leached scaffolds with two levels of a biomimetic calcium phosphate coating to examine their effects on mesenchymal stem cell osteogenesis.
    [Cells Tissues Organs]

    Abstract
    REVIEWS

    Cell and Gene Therapy for Kidney Disease

    The authors describe the potential for cell and gene therapy in treating kidney disease, focusing on recent genetic studies, key advances, and emerging technologies, describing several crucial considerations for renal genetic and cell therapies.
    [Nature Reviews Nephrology]

    Abstract

    Advancing Cell-Based Cancer Immunotherapy through Stem Cell Engineering

    Investigators review stem cell-based immunotherapy approaches, stem cell sources, gene engineering and manufacturing strategies, therapeutic platforms, and clinical trials, as well as challenges and future directions for the field.
    [Cell Stem Cell]

    Abstract
    INDUSTRY AND POLICY NEWS

    Aurion Biotech Receives Approval From Japan’s PMDA For New Drug Application

    Aurion Biotech announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), for its novel cell therapy, VyznovaTM for the treatment of bullous keratopathy of the cornea.
    [Aurion Biotech]

    Press Release
    FEATURED EVENT

    Lund Stem Cell Center 20th Anniversary

    April 17 – 19, 2023
    Lund, Sweden

    > See All Events

    JOB OPPORTUNITIES

    Director – Regional Cell Therapy Operations

    Novartis – East Hanover, New Jersey, United States

    Assistant Professor – Immunology

    Dana-Farber Cancer Institute and Harvard Medical School – Boston, Massachusetts, United States

    Postdoctoral Fellowship – Cancer Research and Tumor Immunology

    Ume̴ University РUme̴, Sweden

    Postdoctoral Associate – Integrated Systems Biology of AML

    University of Florida – Gainesville, Florida, United States

    Postdoctoral Position – Allogeneic Cell Therapy

    Delft University of Technology – Delft, Netherlands

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter